ISSN: 1165-158X

細胞および分子生物学

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

CDK1-Mediated Nuclear Localization of Sox2 Promoted Cell Migration and Invasion in Esophageal Carcinoma Cells

Jin Shi, Tian-Yu Lu, Fang Wang

Highlights:

Expression of CDK1 and Sox2 was correlated with esophageal cancer. CDK1 promoted the migration and invasion of ECA109 cells. CDK1 knockdown inhibited phosphorylation and nuclear localization of Sox2

Background: Esophageal carcinoma is an aggressive malignancy characterized with early metastasis and low 5-year survival rate. Cyclin-dependent kinase 1 (CDK1) is a regulator of cell cycle that also contributes to cell proliferation, migration, invasion and drug resistance in multiple cancers. In this study, we aim to explore the role of CDK1 in the malignant phenotype of esophageal carcinoma and its underlying mechanism.

Methods: The expression of CDK1 and SRY-box transcription factor 2 (Sox2) in vivo were analyzed from data mined from GEPIA. Cell migration and invasion ability were analyzed by cell migration assay and transwell invasion assay. The protein and mRNA levels of indicated genes were detected by western blot and RT-qPCR. Protein to protein interaction was detected by immunoprecipitation.

Results: It was found that CDK1 expression was up-regulate in esophageal carcinoma and facilitated cell migration and invasion in vitro. Molecularly, we showed that CDK1 directly interacted with transcriptional factor Sox2, which was also up-regulated in esophageal carcinoma from GEPIA database. CDK1 knockdown inhibited the phosphorylation of Sox2 and facilitated its translocation from nucleus to cytoplasm.

Conclusion: These findings indicate that CDK1-mediated phosphorylation and nuclear localization of Sox2 plays a crucial role in the malignant phenotype in carcinoma and proposes CDK1 as a potential target in the clinical treatment of esophageal carcinoma.